Marrone Bio Innovations, Inc. EBITDA Margin 2013-2022 | MBII
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Marrone Bio Innovations, Inc. (MBII) over the last 10 years. The current EBITDA margin for Marrone Bio Innovations, Inc. as of March 31, 2022 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2022-03-31 |
$0.05B |
$-0.01B |
-31.11% |
2021-12-31 |
$0.05B |
$-0.01B |
-22.22% |
2021-09-30 |
$0.04B |
$-0.01B |
-21.43% |
2021-06-30 |
$0.04B |
$-0.01B |
-24.39% |
2021-03-31 |
$0.04B |
$-0.01B |
-25.00% |
2020-12-31 |
$0.04B |
$-0.01B |
-33.33% |
2020-09-30 |
$0.04B |
$-0.02B |
-44.74% |
2020-06-30 |
$0.04B |
$-0.02B |
-61.11% |
2020-03-31 |
$0.03B |
$-0.03B |
-87.10% |
2019-12-31 |
$0.03B |
$-0.03B |
-83.33% |
2019-09-30 |
$0.03B |
$-0.02B |
-79.31% |
2019-06-30 |
$0.03B |
$-0.02B |
-66.67% |
2019-03-31 |
$0.03B |
$-0.02B |
-61.54% |
2018-12-31 |
$0.02B |
$-0.02B |
-85.71% |
2018-09-30 |
$0.02B |
$-0.02B |
-100.00% |
2018-06-30 |
$0.02B |
$-0.02B |
-117.65% |
2018-03-31 |
$0.02B |
$-0.02B |
-123.53% |
2017-12-31 |
$0.02B |
$-0.02B |
-123.53% |
2017-09-30 |
$0.02B |
$-0.02B |
-129.41% |
2017-06-30 |
$0.02B |
$-0.02B |
-123.53% |
2017-03-31 |
$0.02B |
$-0.02B |
-125.00% |
2016-12-31 |
$0.02B |
$-0.02B |
-146.67% |
2016-09-30 |
$0.01B |
$-0.02B |
-171.43% |
2016-06-30 |
$0.01B |
$-0.03B |
-225.00% |
2016-03-31 |
$0.01B |
$-0.03B |
-330.00% |
2015-12-31 |
$0.01B |
$-0.04B |
-400.00% |
2015-09-30 |
$0.01B |
$-0.04B |
-537.50% |
2015-06-30 |
$0.01B |
$-0.05B |
-600.00% |
2015-03-31 |
$0.01B |
$-0.05B |
-587.50% |
2014-12-31 |
$0.01B |
$-0.05B |
-511.11% |
2014-09-30 |
$0.01B |
$-0.04B |
-537.50% |
2014-06-30 |
$0.01B |
$-0.04B |
-542.86% |
2014-03-31 |
$0.01B |
$-0.04B |
-388.89% |
2013-12-31 |
$0.01B |
$-0.03B |
-344.44% |
2013-09-30 |
$0.01B |
$-0.03B |
-241.67% |
2013-06-30 |
$0.01B |
$-0.03B |
-225.00% |
2013-03-31 |
$0.01B |
$-0.03B |
-277.78% |
2012-12-31 |
$0.01B |
$-0.02B |
-300.00% |